- Home
- INDV
INDV
Indivior PLC
as of 12-05-2025 3:45pm EST
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
| Founded: | 1994 | Country: | United States |
| Employees: | N/A | City: | SLOUGH, BERKSHIRE |
| Market Cap: | 4.1B | IPO Year: | N/A |
| Target Price: | $32.50 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.98 | EPS Growth: | N/A |
| 52 Week Low/High: | $7.62 - $35.31 | Next Earning Date: | 10-30-2025 |
| Revenue: | $1,180,000,000 | Revenue Growth: | -0.17% |
| Revenue Growth (this year): | 1.09% | Revenue Growth (next year): | -5.33% |
AI-Powered INDV Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare INDV vs Leading Stocks
See how INDV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "INDV Indivior PLC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.